Transition Bio, Inc. Alternatives & Competitors

12 companies similar to Transition Bio, Inc. — The only end-to-end condensate drug discovery platform built on molecular insigh...

Kimia Therapeutics

37 Series A $55.00M

Berkeley, United States

Biotechnology Health and Wellness

VRG Therapeutics

Technology-driven biotech with an AI-powered miniprotein RnD platform

33 Series A $8.40M

Budapest, Hungary

Valo Health

Cloud computing as well as longitudinal and human data to create an entirely new drug disc...

212 Unknown $334.50M

Lexington, United States

Biotechnology

Enhanced Genomics

Discover. Target. Cure.

11 Series A $10.00M

Cambridge, United Kingdom

Biotechnology

Track all Transition Bio, Inc. competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

Start Tracking — Free

Peptone

Drugging disordered proteins with physics and AI

45 Series A $42.00M

London, United Kingdom

Biotechnology Pharmaceutical

remynd

30 Series B $24.00M

Belgium

Biotechnology Manufacturing

Metrion Biosciences

Specialist preclinical CRO

42 Series C $7.84M

Cambridge, United Kingdom

Biotechnology Health Care +1

Alioth Biotech

Your Reliable Partner in Pharma Filtration Processing

22 Series A $190.00M

China

Biopharma Biotechnology +2

InterAx Biotech

Advanced integration of biological systems, math models and artificial intelligence

17 Series A $3.20M

Switzerland

AI Biopharma +4

GenEdit

Delivering the potential of genetic medicines

47 Series A $67.73M

South San Francisco, Unit...

Biotechnology Health and Wellness +1

BDD

Redefining Early Stage Development

54 Series Unknown $5.20M

United Kingdom

Biopharma Biotechnology +3

Acrigen Biosciences

Developing life-saving genetic therapies using our proprietary precision gene editing tech...

6 Seed $1.23M

Alameda, United States

Biotechnology Life Sciences

About Transition Bio, Inc.

The only end-to-end condensate drug discovery platform built on molecular insights.

Services

Drug discovery platform, Molecular level insights, Microfluidics technology, AI-driven chemical optimization

Target Customers

Pharmaceutical companies, Biotech firms, Medical research institutions

Taxonomy

Condensate Drug Discovery, Molecular Insights, Biomolecular Condensates, Condensomics Platform, Biophysics-Driven Drug Development, Artificial Intelligence In Drug Discovery, Droplet Microfluidics, Cellular Platforms, Condensate Characterization, Proprietary Data Sets, Target Discovery, Target Validation, Drug Design, Diagnostics, Hypothesis-Free Drug Development

Business Model

B2B, SaaS, Platform

Revenue Model

Licensing, Service Fee, Performance Based

Frequently Asked Questions

Top alternatives to Transition Bio, Inc. include Kimia Therapeutics, VRG Therapeutics, Valo Health, Enhanced Genomics, Peptone. These companies serve similar markets and are frequently compared.

Bounce Watch tracks 12 companies similar to Transition Bio, Inc. based on industry overlap, target customers, and business model.

The only end-to-end condensate drug discovery platform built on molecular insights.

Don't just browse. Track.

Signal Tracker monitors Transition Bio, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types.

Start Tracking Companies — Free

Explore Related

Transition Bio, Inc. Profile VRG Therapeutics Alternatives Enhanced Genomics Alternatives Peptone Alternatives All Companies All Signals Trend Reports